Lavipharm S.A. (ATH: LAVI)

Lavipharm Revenue

Lavipharm had revenue of 13.14M EUR in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to 51.34M, up 17.35% year-over-year. In the year 2023, Lavipharm had annual revenue of 50.93M with 30.40% growth.

• Revenue (ttm): 51.34M
• Revenue Growth: +17.35%
• P/S Ratio: 2.83
• Revenue / Employee: 171.15K
• Employees: 307
• Market Cap: 145.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	50.93M	11.87M	30.40%
Dec 31, 2022	39.06M	-667.00K	-1.68%
Dec 31, 2021	39.72M	2.09M	5.54%
Dec 31, 2020	37.64M	4.05M	12.06%
Dec 31, 2019	33.59M	-470.00K	-1.38%